|
May 24
|
Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle
|
|
May 22
|
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
|
|
May 22
|
Snowflake stock gains, Nvidia & Navitas, Hims & Hers slips
|
|
May 22
|
Nvidia, Tesla lead over $250 billion in short-seller losses during massive market rally
|
|
Apr 30
|
Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead
|
|
Apr 29
|
Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap
|
|
Apr 29
|
Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy
|
|
Apr 29
|
Hims-Novo Nordisk partnership, SoFi earnings, Spotify guidance
|
|
Apr 29
|
Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership
|
|
Apr 29
|
Hims & Hers with Novo Nordisk, Hilton, PayPal: Trending Tickers
|
|
Apr 29
|
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
|
|
Apr 25
|
Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
|
|
Apr 17
|
Eli Lilly stock soars on positive weight-loss pill results
|
|
Apr 16
|
April 2025's Top Growth Stocks With Strong Insider Confidence
|
|
Apr 14
|
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
|
|
Apr 4
|
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
|
|
Apr 3
|
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
|
|
Apr 2
|
Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
|
|
Apr 2
|
Who Should Pay for Ozempic Is the Next Big Workplace Fight
|
|
Apr 1
|
Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform
|